Status:
UNKNOWN
Oncological Surgery in Times of COVID-19: Effectiveness of Preoperative Screening for Sars-Cov-2
Lead Sponsor:
Instituto Brasileiro de Controle do Cancer
Conditions:
SARS-CoV-2
Oncology
Eligibility:
All Genders
18+ years
Brief Summary
To evaluate the incidence of patients with a positive test for SARS-CoV-2, performed in the preoperative screening for patients treated at the institution
Detailed Description
Cohort, prospective, observational study to evaluate the incidence of asymptomatic patients with a positive SARS-CoV-2 test detected in the preoperative screening program of the institution.
Eligibility Criteria
Inclusion
- Patients with elective surgery scheduled at the IBCC, including those diagnosed with any type of cancer;
- Patients who will undergo the screening test for SARS-COV-2 by RT-PCR (nasal swab), according to the guidelines and protocol of the hospital
Exclusion
- Urgent or emergency surgery;
- Screening test for SARS-COV-2 not performed
- Incomplete data in the institutional database
Key Trial Info
Start Date :
May 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2021
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT04434261
Start Date
May 11 2020
End Date
September 30 2021
Last Update
March 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Instituto Brasileiro de Controle do Cancer - IBCC
São Paulo, Brazil